Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation (Q30308011)

16 June 2017

title

Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation (English)

1 reference

16 June 2017

1 reference

Zhao MQ

1

1 reference

16 June 2017

Amir MK

series ordinal

2

1 reference

16 June 2017

Rice WR

series ordinal

3

1 reference

16 June 2017

Enelow RI

series ordinal

4

1 reference

16 June 2017

publication date

1 September 2001

1 reference

American Journal of Respiratory Cell and Molecular Biology

16 June 2017

published in

1 reference

16 June 2017

volume

25

1 reference

16 June 2017

issue

3

1 reference

16 June 2017

page(s)

362-369

1 reference

Distinct types of lung disease caused by functional subsets of antiviral T cells

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

To kill or to cure: options in host defense against viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Immunopathological mechanisms in respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Immune function in mice lacking the perforin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

A lung-specific neo-antigen elicits specific CD8+ T cell tolerance with preserved CD4+ T cell reactivity. Implications for immune-mediated lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Partial activation of CD8+ T cells by a self-derived peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

T cell receptor antagonist peptides induce positive selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Initial and innate responses to viral infections--pattern setting in immunity or disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Virus-specific CD8+ T cells in primary and secondary influenza pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

C-C chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

Regulated commitment of TNF receptor signaling: a molecular switch for death or activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.3.4476

21 January 2018

Identifiers

DOI

10.1165/AJRCMB.25.3.4476

1 reference

16 June 2017

1 reference